Senate committee backs Trump's DOL secretary nominee

By Allison Bell – Keith Sonderling moved a step closer Thursday toward becoming a confirmed secretary of Labor. Members of the U.S. Senate Health, Education, Labor and Pensions Committee voted 12-11 to back his nomination. President Donald Trump nominated Sonderling to the post in June. Sonderling has been the acting Labor Department secretary since April, when the previous Labor Department secretary, Lori Chavez-DeRemer, resigned. Read Full Article... ^{_{(Subscription required)}}

HVBA Article Summary

1. Committee Approval Sends Nomination to Full Senate: The Senate Health, Education, Labor and Pensions Committee advanced Keith Sonderling’s nomination by a narrow margin, moving it to the Senate floor for further consideration. The split vote reflected partisan divisions, with Democrats opposing the nomination and Republicans supporting it. A final confirmation vote by the full Senate will determine whether he officially becomes Labor secretary. The outcome could influence the direction of federal labor and benefits policy.

2. Potential Impact on Health and Retirement Policy: If confirmed, Sonderling would play a central role in shaping federal oversight of employer-sponsored health plans, retirement plans and personal savings accounts. The Labor Department has historically asserted authority under ERISA to regulate retirement account asset transfers and rollover practices, including annuities and other financial products. His leadership could affect how aggressively the department interprets and enforces those powers. That, in turn, would have implications for employers, plan sponsors and financial services providers.

3. Broader Debate During Confirmation Session: Although the vote concerned Sonderling, much of the committee’s discussion focused on Sean Kaufman, a nominee for a senior HHS preparedness role. Senators debated Kaufman’s past public statements about vaccines, with critics questioning his views and supporters noting assurances about limiting his role in vaccine policy. The exchange highlighted broader partisan tensions over public health policy and executive branch appointments. These dynamics formed the backdrop to the committee’s action on the Labor secretary nomination.

Revised 340B Rebate Model Pilot Program moves forward, despite provider pushback

By Dave Muoio – The Health Resources and Services Administration has unveiled its formal plans for a revised version of its contentious 340B Rebate Model Pilot Program, a test run in which statutory upfront discounts for safety-net providers would be swapped out for drug manufacturer-directed rebates. Read Full Article...

HVBA Article Summary

1. Pilot Expansion and Timeline Details: The revised pilot is scheduled to begin Jan. 1, 2027, with manufacturers required to submit participation plans by Aug. 24, 2026, and receive approval by Sept. 24, 2026. The program will run for at least one year, and HRSA has pledged to publish interim updates and a full evaluation by April 30, 2028. Compared to the earlier version, the scope has grown from 10 drugs and eight manufacturers to 25 products from 13 companies. Even so, those drugs account for less than 5.5% of total 340B sales in 2025, according to HRSA.

2. Debate Over Administrative Burden and Costs: Hospitals and covered entities argue the rebate model will impose significant administrative and liquidity challenges, estimating total costs could exceed $1 billion rather than HRSA’s projection of about $523.3 million, or $34,320 per entity. HRSA disputes those claims, stating that many assumptions overstate the operational changes required and that existing infrastructure can be adapted. The agency also emphasizes that manufacturers must bear the costs of building and maintaining the required IT platforms. Industry groups, meanwhile, contend that the model will curb duplicate discounts and improve oversight.

3. Oversight Mechanisms and Stakeholder Reactions: Under the model, covered entities will have 45 days from drug dispensation to submit claims data, and manufacturers must issue rebates within 10 days of a completed submission. HRSA outlined enforcement tools, including potential removal of manufacturers from the pilot if more than 5% of sampled transactions are denied without acceptable justification. Public comments were sharply divided, with providers largely opposing the plan and manufacturers and some advocacy groups supporting it. The policy continues to intensify longstanding tensions over the 340B program, which has surpassed $100 billion in annual sales and remains the focus of litigation and legislative proposals.

Hackers steal patient data in Amgen cloud breach

By Ayisha Sharma – Amgen said Friday that hackers have stolen company and patient information in a data breach. The company said it noticed “unauthorized activity” affecting data stored on cloud platforms hosted by third-party providers in July, according to an SEC filing. It rolled out a cybersecurity response plan and has since discovered that the unnamed hackers accessed “proprietary data” and “patient protected health information.” Read Full Article... ^{_{(Subscription required)}}

HVBA Article Summary

1. Amgen Investigates Cybersecurity Incident: Amgen disclosed that it is investigating a cybersecurity breach to determine the full extent of the incident and identify what additional information may have been accessed or stolen. The company is also evaluating any potential operational and business impacts resulting from the attack. At this time, Amgen stated that it does not expect the incident to have a material impact on its financial condition and has not released further details.

2. Cyberattacks Continue to Target Major Pharmaceutical Companies: Amgen’s disclosure follows a series of recent cyberattacks affecting large pharmaceutical manufacturers. In June, Novo Nordisk reported that hackers stole AI models, pipeline product information, and proprietary manufacturing details related to its blockbuster medicines. Two separate extortion groups demanded $25 million and $50 million, respectively, for the stolen data, but Novo Nordisk declined both ransom demands.

3. Healthcare Sector Remains a Frequent Target for Cybercrime: The recent incidents highlight continued cybersecurity threats across the healthcare and life sciences industries. In addition to attacks on Amgen and Novo Nordisk, the extortion group ShinyHunters has claimed responsibility for cyberattacks targeting organizations including Medtronic and DentaQuest. These events underscore the ongoing risks companies face from data theft, ransomware, and other cyber threats.

Daffodil Health Launches No Surprises Act Dispute Management Solution

By Marissa Plescia – Daffodil Health, an AI health plan administration platform, unveiled a new solution on Thursday that aims to help payers manage No Surprises Act disputes. The No Surprises Act shields patients from unexpected medical bills by keeping them out of payment disputes between insurers and providers. Read Full Article...

HVBA Article Summary

1. Rising Volume of IDR Cases Is Straining Payers: The No Surprises Act requires insurers and providers to negotiate for 30 days before entering the Independent Dispute Resolution process if no agreement is reached. While the law was originally expected to generate about 17,000 arbitration cases annually, more than 1.2 million cases were filed in just the first half of 2025. Many payers argue that providers are initiating most disputes and frequently prevailing at higher-than-expected award amounts. This surge in volume has increased administrative and financial pressure on health plans.

2. AI-Powered Automation Targets Administrative Burden: Daffodil’s new solution uses automation to read, categorize and respond to disputes submitted by providers. The system also evaluates claims data, pricing benchmarks and arbitration history to recommend whether to pay, counteroffer or proceed to arbitration. For cases that move forward, it can suggest an arbitrator and generate a draft arbitration package for review. The platform is designed to help payers manage growing caseloads without significantly increasing staffing costs.

3. Broader Debate Over Middlemen and Industry Incentives: According to Daffodil’s CEO, the conflict surrounding NSA disputes reflects systemic incentives that reward complexity and friction. He argues that intermediaries on both sides benefit financially from prolonged disputes and administrative inefficiencies. The company positions its technology as a way for payers to reduce reliance on such middlemen, cut administrative expenses and improve margins. At the same time, the solution is intended to provide employer groups with clearer reporting on how disputes are handled and resolved.

Healthcare Employers Can Leverage More Intentional Benefit Design, Delivery

By Emily Boyle – Healthcare employers serve a workforce that is diverse in several ways, including economically—from entry-level and support staff to physicians and executives—meaning designing relevant, accessible benefits can be a challenge. However, some financial wellness benefits may offer wide-reaching solutions for employers and employees alike, according to a new Commonwealth report, “Workplace Benefits in Healthcare.” Read Full Article...

HVBA Article Summary

1. Emergency Savings as a Foundational Benefit: The report highlights that only 6% of healthcare workers surveyed had access to an employer-supported emergency savings program, yet 27% of those with access ranked it among their most valuable benefits. Research cited in the article suggests that short-term savings access can complement rather than hinder retirement participation. Expanding both in-plan and out-of-plan emergency savings options could therefore strengthen overall financial resilience. For a workforce with varied income levels, this type of benefit may provide broad and immediate impact.

2. Student Loan Support Reflects Sector-Specific Needs: Healthcare workers reported student debt pressures at notable rates, with 12% prioritizing paying off loans and 10% identifying student debt as a major financial challenge. Despite this, only 4% said they had access to employer-sponsored student loan support. The report suggests tools such as student loan retirement matches, tuition reimbursement or direct loan assistance to address this gap. These approaches may help employers retain talent in roles that often require advanced education and ongoing certification.

3. Broader Financial Wellness and Benefit Design Strategies: The Commonwealth report encourages employers to promote health savings accounts alongside high-deductible health plans, including through employer contributions and clearer communication. It also recommends complementary offerings such as 529 college savings plans with payroll integration, tax-time assistance and financial coaching to improve engagement. Additional benefits like caregiving and transportation support could help reduce absenteeism and improve workforce stability. Collectively, these strategies are positioned as ways to enhance employee financial well-being while advancing retention and engagement goals.

A look at employers' attitudes toward ICHRAs

By Paige Minemyer – As employers face a continued rise in healthcare costs, ICHRAs do hold promise, but barriers to adoption remain, according to a new survey. The Employee Benefit Research Institute and Morgan Health teamed up to poll 984 benefit decision-makers at employers across a variety of sizes between March and May, and found that more than a third are either planning or evaluating an individual coverage health reimbursement arrangement, or ICHRA. Read Full Article...

HVBA Article Summary

1. Employers Are Interested but Cautious: The survey of 984 benefits decision-makers found that more than a third are either planning or evaluating an ICHRA, signaling meaningful curiosity about the model. However, only 11% are actively planning to implement one, indicating that most organizations remain in an exploratory phase. This gap suggests that while awareness is growing, employers are hesitant to make immediate changes to their benefits structures.

2. Awareness and Employer Size Influence Adoption: Familiarity with ICHRAs varies widely, with six in 10 employers saying they are at least somewhat familiar with the option. Interest is strongest among employers with 100 or more workers, as 62% said they were somewhat or very likely to offer one within two years. In contrast, more than half of small employers that do not currently offer coverage were unaware that ICHRAs are available, highlighting an educational barrier that could limit uptake.

3. Concerns About Market Stability and Administration Persist: Employers cited affordability and flexibility as potential advantages of ICHRAs, but they also expressed concern about the stability of the individual insurance market. Questions remain about whether premiums, out-of-pocket costs, plan quality and provider networks would meet employees’ needs. Administrative complexity and uncertainty about long-term viability further dampen enthusiasm, though broker or consultant recommendations significantly increase employer openness to adoption.

Obesity and Cognitive Problems: Understanding the Connection

By Erica Lamberg – Understanding the multifaceted relationship between obesity and cognitive function is vital for advancing patient care. Research shows that excess body weight can affect mental sharpness and increase the risk of neurocognitive disorders, highlighting the importance of comprehensive clinical care. Read Full Article...

HVBA Article Summary

1. Biological Pathways Link Obesity to Cognitive Decline: Experts describe multiple mechanisms through which obesity may impair brain health, including inflammatory cascades driven by cytokines, oxidative stress, and free radicals. Obesity-related inflammation can disrupt insulin regulation, raise blood glucose levels, and potentially contribute to amyloid buildup in the brain. In addition, metabolic conditions commonly associated with obesity—such as diabetes, hypertension, and hyperlipidemia—substantially raise vascular risk, which is closely tied to cognitive decline.

2. Gut-Brain and Lifestyle Factors Play a Role: Structural changes in the gut microbiome associated with obesity may promote inflammation and insulin resistance, allowing harmful mediators to cross the blood-brain barrier and affect memory-related regions such as the hippocampus. Obesity is also linked to sleep apnea, an independent risk factor that can impair cognition and quality of life. Reduced physical activity, social isolation, poor sleep, and limitations in daily functioning may further compound cognitive challenges.

3. Comprehensive, Patient-Centered Management Is Recommended: Clinicians emphasize discussing the cognitive and mental health dimensions of obesity with patients, not just its physical consequences. Recommended strategies include promoting gradual, sustained weight loss; encouraging physical, mental, and social activity; and managing vascular risk factors such as elevated blood pressure, blood sugar, and lipid abnormalities. While GLP-1 receptor agonists improve blood sugar control and support weight loss, further conclusive clinical evidence is still needed to determine their direct impact on cognitive decline.